Down-regulation of epidermal growth factor receptor by selective expansion of a 5′-end regulatory dinucleotide repeat in colon cancer with microsatellite instability

Clinical Cancer Research

Volumn 15, Issue 14, 2009, Pages 4531-4537

  Baranovskaya, Svetlana ^a   Martin, Yolanda ^a   Alonso, Sergio ^a   Pisarchuk, Ksenia L ^a   Falchetti, Mario ^a   Dai, Yuichi ^a   Khaldoyanidi, Sophia ^b   Krajewski, Stan ^a   Novikova, Inna ^c   Sidorenko, Yuri S ^c   Perucho, Manuel ^a   Malkhosyan, Sergei R ^a  

^a BURNHAM INSTITUTE   (United States)

^b TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^c Rostov Service Institute   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; COLON CANCER; DOWN REGULATION; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; STOMACH CANCER;

5' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL LINE, TUMOR; COLONIC NEOPLASMS; DINUCLEOTIDE REPEATS; DNA MUTATIONAL ANALYSIS; DOWN-REGULATION; FLOW CYTOMETRY; GENE FREQUENCY; GENES, RAS; GENOTYPE; HUMANS; MICROSATELLITE INSTABILITY; MUTAGENESIS, INSERTIONAL; MUTATION; POLY A; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS B-RAF; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEQUENCE DELETION; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 68049110642     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1282     Document Type: Article

References (40)

1. Savage CR, Jr., Cohen S. Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization. J Biol Chem 1972;247:7609-7611
2. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 1987;56:881-914.
3. Huang SM, Harari PM. Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results. Invest New Drugs 1999;17:259-269
4. Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer 2001;37:S9-15.
5. Wang X-Y, Smith DI, Frederick L, James CD. Analysis of EGF receptor amplicons reveals amplification of multiple expressed sequences. Oncogene 1998;16:191-195
6. Ishii S, Xu YH, Stratton RH, Roe BA, Merlino GT, Pastan I. Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. Proc Natl Acad Sci U S A 1985;82:4920-4924 (Pubitemid 15249917)
7. Maekawa T, Itoh F, Okamoto T, Kurimoto M, Imamoto F, Ishii S. Identification and purification of the enhancer-binding factor of human immunodeficiency virus-1. Multiple proteins and binding to other enhancers. J Biol Chem 1989;264:2826-2831 (Pubitemid 19057777)
8. Gebhardt F, Zanker KS, Brandt B. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J Biol Chem 1999;274:13176-13180 (Pubitemid 129518521)
9. Gebhardt F, Burger H, Brandt B. Modulation of EGFR gene transcription by secondary structures, a polymorphic repetitive sequence and mutations - a link between genetics and epigenetics. Histol Histopathol 2000;15:929-936 (Pubitemid 30488572)
10. Aaltonen LA, Peltomäki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-816 (Pubitemid 23167611)
11. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-819 (Pubitemid 23167612)
12. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-561 (Pubitemid 23186645)
13. Woerner SM, Benner A, Sutter C, et al. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative real common target genes. Oncogene 2003;22:2226-2235 (Pubitemid 36566779)
14. Perucho M. Correspondence re: C.R. Boland, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257
15. Baranovskaya S, Soto JL, Perucho M, Malkhosyan SR. Functional significance of concomitant inactivation of hMLH1 and hMSH6 in tumor cells of the microsatellite mutator phenotype. Proc Natl Acad Sci U S A 2001;98:15107-15112 (Pubitemid 34013977)
16. Luria SE, Delbrück M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 1943;28:491-511.
17. Krajewska M, Kim H, Shin E, et al. Tumor-associated alterations in caspase-14 expression in epithelial malignancies. Clin Cancer Res 2005;11:5462-5471 (Pubitemid 41060822)
18. Yamamoto H, Perez-Piteira J, Yoshida T, et al. Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 1999;116:1348-1357 (Pubitemid 29258883)
19. Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997;57:2140-2143
20. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-954 (Pubitemid 34716871)
21. Liu W, Innocenti F, Chen P, Das S, Cook EH, Jr., Ratain MJ. Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism. Clin Cancer Res 2003;9:1009-1012 (Pubitemid 36323704)
22. Ruggiero T, Olivero M, Follenzi A, Naldini L, Calogero R, Di Renzo MF. Deletion in a (T)8 microsatellite abrogates expression regulation by 3′-UTR. Nucleic Acids Res 2003;31:6561-6569 (Pubitemid 37508761)
23. Puga I, Lainez B, Fernandez-Real JM, et al. A polymorphism in the 3′ untranslated region of the gene for tumor necrosis factor receptor 2 modulates reporter gene expression. Endocrinology 2005;146:2210-2220 (Pubitemid 40577508)
24. Aaronson SA. Growth factors and cancer. Science 1991;254:1146-1153
25. De Larco JE, Todaro GJ. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci U S A 1978;75:4001-4005
26. Marquardt H, Todaro GJ. Human transforming growth factor. Production by a melanoma cell line, purification, and initial characterization. J Biol Chem 1982;257:5220-5225 (Pubitemid 12054843)
27. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 2000;1:169-178
28. Koenders PG, Peters WH, Wobbes T, Beex LV, Nagengast FM, Benraad TJ. Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue. Br J Cancer 1992;65:189-192
29. Markowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-1338
30. Armstrong DK, Kaufmann SH, Ottaviano YL, et al. Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res 1994;54:5280-5283 (Pubitemid 24336014)
31. Hognason T, Chatterjee S, Vartanian T, Ratan RR, Ernewein KM, Habib AA. Epidermal growth factor receptor induced apoptosis: potentiation by inhibition of Ras signaling. FEBS Lett 2001;491:1-3. (Pubitemid 32171991)
32. Konishi M, Kikuchi-Yanoshita R, Tanaka K, et al. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 1996;111:307-317 (Pubitemid 26256718)
33. Rampino N, Yamamoto H, Ionov Y, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275:967-969 (Pubitemid 27087710)
34. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971;68:820-823
35. Yamamoto H, Gil J, Schwartz S, Jr., Perucho M. Frameshift mutations in Fas, Apaf-1, and Bcl-10 in gastro-intestinal cancer of the microsatellite mutator phenotype. Cell Death Differ 2000;7:238-239
36. Yamamoto H, Yamashita K, Perucho M. Somatic mutation of the beta2-microglobulin gene associates with unfavorable prognosis in gastrointestinal cancer of the microsatellite mutator phenotype. Gastroenterology 2001;120:1565-1567 (Pubitemid 32322336)
37. Malkhosyan S, Rampino N, Yamamoto H, Perucho M. Frameshift mutator mutations. Nature 1996;382:499-500.
38. Ohmiya N, Matsumoto S, Yamamoto H, Baranovskaya S, Malkhosyan SR, Perucho M. Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype. Gene 2001;272:301-313 (Pubitemid 32695423)
39. Montero AJ, Diaz-Montero CM, Mao L, et al. Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer. Cancer Biol Ther 2006;5:1494-1501 (Pubitemid 46256620)
40. Voldborg BR, Damstrup L, Spang-Thomsen M, Poulsen HS. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol 1997;8:1197-1206 (Pubitemid 28164074)